Optimizing Immunity to Vaccines
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 433
Special Issue Editors
Interests: non-specific (heterologous) effects of vaccines; health interventions; health intervention interaction; child mortality; global health; sex-differences; pediatrics
2. International Collaborations & Initiatives, Department of Immunology, University of Toronto, Toronto, ON, Canada
3. Department of Paediatrics, University of Toronto, Toronto, ON, Canada
Interests: interferons; chemokines; infectious diseases; autoimmune diseases; antivirals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
There is increasing evidence that vaccines, in addition to their disease-specific effects, have important off-target or nonspecific effects (NSEs). A number of major attributes/observations with significant implications for child survival have been identified, and it is clear that immunological explanations are required to understand the mechanisms that determine the NSEs of vaccines. The aim of the Special Issue is to bring together epidemiologists, clinicians, and immunologists to document why and how vaccines may have NSEs and why they differ between sexes and at different ages. Examples of topics of interest include: NSEs of live and nonlive vaccines, innate immune training, heterologous immunity, effects of vaccines on the epigenome, sex differences in vaccine responses, off-target uses of vaccines, and vaccinations in the elderly and veterinary vaccinations.
Prof. Christine Stabell Benn
Prof. Eleanor N. Fish
Dr. Rebecca E. Chandler
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nonspecific effects
- innate immune training
- heterologous
- off-target
- sex differences
- aging
- immunoscenescence
- epigenetics
